MedPath
PPB Approval

TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML

HK-66613

Prescription only Medicines

March 30, 2020

Company Information

Company Details

22/F, CTF LIFE TOWER, 18, SHEUNG YUET ROAD, KOWLOON BAY, KOWLOON

Active Ingredients

atezolizumab

Drug Monographs

Atezolizumab

阿替利珠单抗

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML - PPB 批准文号 | MedPath